Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi competitive analysis

Latest publications and patents of Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi New

Explore the latest publications and patents granted to Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi, showcasing their recent innovations and technological advancements.

Last updated on: Sep 27, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi

Jan 3, 2018Effervescent Cefdinir FormulationNo Opposition Filed Within Time Limit

Explore patent oppositions filed by Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Oct 2, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

Methods Of Treating Pulmonary Arterial HypertensionACTELION PHARMACEUTICALSJun 3, 2025
Pharmaceutical Composition For The Treatment Of Pulmonary Arterial HypertensionACTELION PHARMACEUTICALSFeb 21, 2025
Dosing Regimen Associated With Long Acting Injectable Paliperidone EstersJANSSEN PHARMACEUTICADec 20, 2021
Controlled Release Pharmaceutical CompositionASTELLAS PHARMASep 29, 2021
Pharmaceutical Combinations Of An Angiotensin Receptor Antagonist And An Nep InhibitorNOVARTISApr 7, 2021
(+)-2-[1-(3-Ethoxy-4-Methoxyphenyl)-2-Methylsulfonylethyl]-4-Acetylaminoisoindoline-1,3-Dione: Methods Of Using And Compositions ThereofAMGEN EUROPEOct 15, 2019

Latest PTAB cases involving Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi

Discover the latest PTAB cases involving Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 2, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases FacedStrategy Type
SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI6 - - - Highly Aggressive
ACTELION PHARMACEUTICALS - 1821Defensive
AMGEN EUROPE226 - - Defensive
ASTELLAS PHARMA - 31 - 1Non-Active